↓ Skip to main content

A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL

Overview of attention for article published in PLOS ONE, October 2013

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL
Published in
PLOS ONE, October 2013
DOI 10.1371/journal.pone.0077155
Pubmed ID
Authors
Abstract

Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is in part driven by the tyrosine kinase bcr-abl, but imatinib does not produce long-term remission. Therefore, second-generation ABL inhibitors are currently in clinical investigation. Considering different target specificities and the pronounced genetic heterogeneity of Ph+ ALL, which contributes to the aggressiveness of the disease, drug candidates should be evaluated with regard to their effects on the entire Ph+ ALL-specific signaling network. Here, we applied an integrated experimental and computational approach that allowed us to estimate the differential impact of the bcr-abl inhibitors nilotinib, dasatinib, Bosutinib and Bafetinib. First, we determined drug-protein interactions in Ph+ ALL cell lines by chemical proteomics. We then mapped those interactions along with known genetic lesions onto public protein-protein interactions. Computation of global scores through correlation of target affinity, network topology, and distance to disease-relevant nodes assigned the highest impact to dasatinib, which was subsequently confirmed by proliferation assays. In future, combination of patient-specific genomic information with detailed drug target knowledge and network-based computational analysis should allow for an accurate and individualized prediction of therapy.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Sweden 1 2%
Mexico 1 2%
Spain 1 2%
Austria 1 2%
Unknown 47 92%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 11 22%
Student > Ph. D. Student 8 16%
Student > Master 7 14%
Student > Bachelor 4 8%
Student > Postgraduate 2 4%
Other 3 6%
Unknown 16 31%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 13 25%
Medicine and Dentistry 7 14%
Biochemistry, Genetics and Molecular Biology 5 10%
Chemistry 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 5 10%
Unknown 16 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2015.
All research outputs
#27,938,092
of 34,622,316 outputs
Outputs from PLOS ONE
#177,719
of 225,268 outputs
Outputs of similar age
#202,164
of 258,667 outputs
Outputs of similar age from PLOS ONE
#4,517
of 5,672 outputs
Altmetric has tracked 34,622,316 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 225,268 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.2. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,667 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5,672 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.